SUZ
Suzano S.A.
There isn't enough reported data to score SUZ yet.
SUZ Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Under pressure |
SUZ's profitability is currently healthy, but its balance sheet is under pressure. There isn't enough data to rate its revenue and cash flow.
SUZ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 8.2x | $9.82 | — |
| Cheap | 114x | $138 | +1304% |
| Fair | 261x | $316 | +3113% |
| Expensive | 289x | $350 | +3462% |
Historical ranges are pointers, not guarantees.
SUZ's PE is 8.2x, but its earnings don't support one, so it isn't a reliable read right now.
SUZ Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect SUZ's revenue to grow, but its earnings and profitability to decline.
SUZ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $1.94 | +$2.94 |
| Q2 2025 | $1.13 | +2725% |
| Q4 2024 | -$1.00 | -152% |
| Q2 2024 | $0.04 | -99% |
| Q4 2023 | $1.94 | -38% |
| Q4 2022 | $3.15 | +176% |
| Q4 2021 | $1.14 | +$2.56 |
| Q4 2020 | -$1.42 | -$1.05 |
SUZ's earnings per share have fallen from their peak: $1.21 over the past year, against $3.16 in mid-2023.
SUZ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7B | +222% |
| Q4 2025 | $2.3B | -50% |
| Q2 2025 | $2.4B | -37% |
| Q4 2024 | $4.7B | +37% |
| Q2 2024 | $3.8B | +2.5% |
| Q4 2023 | $3.5B | -32% |
| Q2 2023 | $3.7B | -3.9% |
| Q4 2022 | $5.1B | -30% |
SUZ's revenue has held roughly level: $7B last quarter, up 238% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | -3.8 points |
| Q4 2025 | 27% | -5.2 points |
| Q3 2025 | 16% | -18 points |
| Q2 2025 | 23% | -2.1 points |
| Q1 2025 | 20% | -17 points |
| Q4 2024 | 32% | -18 points |
| Q2 2024 | 34% | -3.3 points |
| Q4 2023 | 25% | -19 points |
SUZ's operating margin was 16% last quarter, down 3.8 points from the same quarter a year ago, near the bottom of its range since 2016.
SUZ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +1460% |
| Q4 2025 | $752.9M | -43% |
| Q2 2025 | $203.7M | -72% |
| Q4 2024 | $1.3B | +546% |
| Q2 2024 | $733.6M | -9.1% |
| Q4 2023 | $202.8M | -78% |
| Q2 2023 | $807.2M | -32% |
| Q4 2022 | $928M | -67% |
SUZ still generates free cash flow, though less than at its 2021 peak: $2.7B over the past year.
SUZ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2.7M shares |
| 1 year | -0.4% | -5.2M shares |
| 3 years | +13% | +144M shares |
SUZ has 1.2B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $35.5M |
| Q4 2025 | — |
| Q3 2025 | $810,325 |
| Q2 2025 | $27.4M |
| Q1 2025 | $6.9M |
| Q4 2024 | $447M |
| Q2 2024 | $55.5M |
| Q4 2023 | $28.6M |
SUZ Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.8x | Elevated |
| Q4 2025 | 2.6x | Moderate |
| Q2 2025 | 2.9x | Moderate |
| Q4 2024 | 3.7x | Elevated |
| Q2 2024 | 4.1x | High |
| Q4 2023 | 3.5x | Elevated |
| Q2 2023 | 2.2x | Moderate |
| Q4 2022 | 2.2x | Moderate |
SUZ's net debt is about 3.8 years of its operating earnings (EBITDA), down from 4.1 years a year ago.
SUZ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.2 | Neutral |
| Stochastic | 92.9 | Overbought |
SUZ's weekly RSI is 63 (neutral) and its Stochastic is 93 (overbought).
SUZ PE vs Basic Materials Sector
| Metric | SUZ | Sector median | Relative |
|---|---|---|---|
| PE | 8.2x | 19x | 56% below |
| PE % | 15 | 40 | 25 pts below |
SUZ is trading at 8.2x earnings, a 56% discount to the Basic Materials sector's median of 19x, though its earnings don't support one.
SUZ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.95 | 9.7% above |
| 20 week MA | $8.72 | 13% above |
| 50 week MA | $9.10 | 7.9% above |
| 100 week MA | $9.29 | 5.7% above |
| 200 week MA | $9.67 | 1.6% above |
SUZ has climbed back above all five of its weekly moving averages, and it's now 1.6% above its 200-week average.
SUZ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.88 | $10.9 | +11% |
| 2021 | $10.9 | $10.6 | -2.9% |
| 2022 | $10.6 | $9.08 | -15% |
| 2023 | $9.08 | $11.4 | +25% |
| 2024 | $11.4 | $10.0 | -12% |
| 2025 | $10.0 | $9.32 | -7.2% |
| 2026 YTD | $9.32 | $9.82 | +5.4% |
SUZ has finished lower in four of the last six years. It's up 5.4% so far in 2026.